title: The affinity ligand "UPHIT" acylates kappa opioid binding sites in vivo.
authors.affiliation: Laboratory of Clinical Science, NIMH, Bethesda, MD 20892.
authors.forename: L
authors.initials: L
authors.lastname: Band
authors.forename: B R
authors.initials: BR
authors.lastname: de Costa
authors.forename: V
authors.initials: V
authors.lastname: Bykov
authors.forename: A
authors.initials: A
authors.lastname: Pert
authors.forename: K C
authors.initials: KC
authors.lastname: Rice
authors.forename: R B
authors.initials: RB
authors.lastname: Rothman
mesh_terms: D000215:Acylation; D000818:Animals; D044482:Benzeneacetamides; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D003510:Cyclohexanes / Q000378:metabolism*; D006168:Guinea Pigs; D008297:Male; D011759:Pyrrolidines / Q000378:metabolism*; D011957:Receptors, Opioid / Q000187:drug effects / Q000378:metabolism*; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu
chemical_list: D044482:Benzeneacetamides; D003510:Cyclohexanes; D011759:Pyrrolidines; D011957:Receptors, Opioid; D017465:Receptors, Opioid, delta; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; C063077:2-isothiocyanato-4,5-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzeneacetamide